FORTE BIOSCIENCES INC (FBRX) Stock Analyst Earnings Estimates
NASDAQ:FBRX - Nasdaq - US34962G2084 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 40K -20.00% | 18.04M 45,000.00% | 40K -99.78% | -100.00% | 67.502M | 137.7M 103.99% | 210.63M 52.96% | 460.1M 118.44% | |||||||||
| EBITDA YoY % growth | -37.34M -18.80% | -45.22M -21.10% | -60.67M -34.17% | N/A 23.80% | N/A 53.60% | N/A 35.20% | N/A -133.65% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -37.63M -18.74% | -45.85M -21.84% | -61.51M -34.15% | -48.004M 24.76% | N/A 53.57% | N/A 35.32% | -38.658M -133.71% | -38.966M -19.95% | -47.871M -22.85% | -60.507M -26.40% | -57.206M 5.46% | -91.063M -59.19% | -221.796M -143.56% | -194.984M 12.09% | -206.352M -5.83% | -187.657M 9.06% | |
| Operating Margin | -94,075.00% | -254.16% | -153,775.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -328.58% | -141.60% | -97.97% | -40.79% | |
| EPS YoY % growth | -2,145.00 | N/A 62.33% | -1,027.50 -27.17% | -218.79 59.15% | -39.27 90.83% | -0.89 97.70% | -14.79 -1,566.67% | -16.45 -11.20% | -7.57 53.96% | -2.82 62.75% | -1.69 39.96% | -2.30 -35.84% | -4.60 -99.78% | -2.88 37.29% | -4.03 -39.82% | -2.70 32.91% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.34 28.27% | -0.88 78.07% | -1.42 79.00% | -0.58 87.19% | -0.63 81.04% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.13M -43.07% | -10.443M -33.81% | -16.722M -30.46% | -12.015M -39.23% | -12.794M -40.14% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -4.54 -1,646.15% | -7.27 | 2.73 | 37.53% |
| Q2 2024 Q2Q % growth | -6.75 -1,507.14% | -4.25 | -2.50 | -58.82% |
| Q1 2024 Q2Q % growth | -4.00 | -4.21 | 0.21 | 4.93% |
| Q4 2023 Q2Q % growth | -4.65 -2,749.11% | -7.14 | 2.49 | 34.88% |
| Q3 2023 Q2Q % growth | -0.26 94.22% | % | ||
| Q2 2023 Q2Q % growth | -0.42 -100.00% | % | ||
| Q4 2022 Q2Q % growth | 96.89% | -0.16 | % | |
| Q3 2022 Q2Q % growth | -4.50 66.67% | -3.83 | -0.67 | -17.65% |
| Q2 2022 Q2Q % growth | -0.21 98.05% | -0.19 | -0.02 | -8.36% |
| Q1 2022 Q2Q % growth | 97.73% | -0.20 | % | |
| Q4 2021 Q2Q % growth | -5.25 43.24% | -8.16 | 2.91 | 35.66% |
| Q3 2021 Q2Q % growth | -13.50 -20.00% | -9.31 | -4.19 | -45.04% |
| Q2 2021 Q2Q % growth | -10.75 95.48% | -11.03 | 0.28 | 2.53% |
| Q1 2021 Q2Q % growth | -9.00 94.42% | -13.39 | 4.39 | 32.77% |
| Q4 2020 Q2Q % growth | -9.25 95.07% | -14.62 | 5.37 | 36.73% |
| Q3 2020 Q2Q % growth | -11.25 96.15% | -13.77 | 2.52 | 18.30% |
| Q2 2020 Q2Q % growth | -238.00 11.85% | -4.85 | -233.16 | -4,812.28% |
| Q1 2020 Q2Q % growth | -161.25 41.89% | -168.30 | 7.05 | 4.19% |
| Q4 2019 Q2Q % growth | -187.50 | -218.03 | 30.53 | 14.00% |
| Q3 2019 Q2Q % growth | -292.50 | -267.48 | -25.02 | -9.35% |
| Q2 2019 Q2Q % growth | -270.00 | -289.28 | 19.28 | 6.67% |
| Q1 2019 Q2Q % growth | -277.50 | -386.27 | 108.77 | 28.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | -100.00% | % | ||
| Q1 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2019 Q2Q % growth | 10K | 515.1K | -505.1K | -98.06% |
| Q2 2019 Q2Q % growth | 10K | 426.533K | -416.533K | -97.66% |
| Q1 2019 Q2Q % growth | 10K | 598.23K | -588.23K | -98.33% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 36.2% | 0% | 28.34% |
| Revenue | N/A | N/A | N/A | N/A |